Susan Downes is a Consultant Ophthalmologist at Oxford Eye Hospital, Oxford in post since 2000, and Professor of Ophthalmology at the University of Oxford, and specialises in retinal disorders.
She completed a post-residency Medical Retina fellowship and a Medical Doctorate in inherited retinal degeneration at Moorfields Eye Hospital and the Institute of Ophthalmology, London, UK 1996-1999.
She is Lead for the Age Related Macular Disease and Retinal Genetics services at Oxford Eye Hospital, and Ophthalmology Lead for the Thames Valley and South Midlands for the national Ophthalmology Clinical Research Network.
Her specialist interests include inherited retinal dystrophies, age-related macular degeneration, macular diseases including central serous chorioretinopathy, retinal telangiectasia, and toxic retinopathies as well as the impact of ocular diseases on sleep wake/mood.
She set up the Eye Research Group Oxford (ERGO), for which she is clinical lead. Together with colleagues from Clinical Genetics and Clinical Scientists from the Oxford Clinical Genetics Laboratory, she co-led on the Biomedical Science Centre of Excellence evaluation of Next Generation Sequencing for Ophthalmology testing which led to the first NHS genetic testing for Stargardt disease in Oxford for the UK.
Oxford is now one of three Genomic Centres providing genetic testing for inherited eye diseases in the UK. Susan Downes works closely with the Oxford Clinical Genetics Laboratory on the phenotype-led gene panels setting up and chairing the MDT for this with colleagues.
She was one of the founding members of the United Kingdom Eye Genetics Group (UKEGG) in 2001, and was UKEGG chair in 2016. She is the European Reference Network Lead for Oxford, one of the international centres recognised for rare diseases in Ophthalmology.